688606 Hangzhou Alltest Biotech
- 57.71
- -0.33-0.57%
Hangzhou Alltest Biotech News
Opinions of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on the initial public offering of some restricted shares of Hangzhou Aotai Biotechnology Co., Ltd.
Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. report on the 2024 semi-annual continuous supervision and follow-up report of Hangzhou Aotai Biotechnology Co., Ltd.
Hangzhou Aotai Biotechnology Co., Ltd. 2024 Restricted Stock Incentive Plan Implementation Assessment Management Measures
Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on Hangzhou Aotai Biotechnology Co., Ltd. 2024 Restricted Stock Incentive Plan (Draft)
Verification opinions of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on Hangzhou Aotai Biotechnology Co., Ltd.\'s adjustment of the estimated quota for daily related transactions in 2024
Announcement of Hangzhou Aotai Biotechnology Co., Ltd. on adjusting the estimated amount of daily related transactions in 2024
Verification opinions of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on Hangzhou Aotai Biotechnology Co., Ltd.\'s foreign exchange derivatives trading business
Feasibility analysis report of Hangzhou Aotai Biotechnology Co., Ltd. on developing foreign exchange derivatives trading business
Announcement of Hangzhou Aotai Biotechnology Co., Ltd. on publicly soliciting delegated voting rights for independent directors
Announcement of Resolutions of the 7th Meeting of the Third Board of Directors
Announcement of Resolutions of the Seventh Meeting of the Third Board of Supervisors
Announcement on holding the 2024 semi-annual results briefing
Notice on changes in accounting policies
Semi-annual Evaluation Report on the 2024 “Improve Quality, Increase Efficiency, and Focus on Return” Special Action Plan
Special report on the storage and actual use of funds raised for the 2024 semi-year
Announcement of Resolutions of the Sixth Meeting of the Third Board of Supervisors
Announcement of the resolution of the fifth meeting of the third board of supervisors.
Announcement on adjusting the quota and term for temporarily idle raised funds for cash management.
Swhy Securities Underwriting & Sponsorship Co., Ltd's verification opinion on the adjustment of Hangzhou OT Bio-Technology Co., Ltd's temporarily idle raised funds for cash management quota and duration.
Shenzhen Valuation Online Consulting Limited's independent financial advisor report on Hangzhou Otech Biotechnology Co., Ltd.'s 2022 restricted stock incentive plan for the first vesting period reserved for the fulfillment of attribution conditions.
Analysis
Price Target
No Data
No Data